KWS SAAT

KWS reports a 3% decline in sales for 2025/26 to €1,626.8 million and a sales-driven drop in EBITDA to €343.1 million, while net profit rose to €158.4 million thanks to an improved financial result. For 2026/27 management forecasts organic sales growth of around 3% and an EBITDA margin of 19–20%, which, if achieved, implies an EBITDA of about €335 million and a slight EPS decline to roughly €4.74. At a share price of around €70 this corresponds to a P/E of just under 15; mid-term targets to 2028 are above the current reference values, so upside is limited and the technical picture, after breaking below the 200-day line, should be assessed cautiously. » More on finanzen.net

KWS Saat recorded a sales decline in fiscal year 2025/26 and expects sales to grow again in the current year but foresees hardly any noticeable improvement in profitability. CEO Felix Büchting cited climatic extremes, increased disease pressure and volatile agricultural markets as burdens for farmers and for the business. » More on finanzen.net

Baader Bank has left KWS Saat at 'Add' after the results, with a price target of €85. The seed company's results for the past fiscal year missed expectations, but the solid outlook for 2026/27 is nonetheless below consensus estimates. » More on finanzen.net

KWS SAAT wants to grow again after an organic sales decline of 1% in fiscal 2025/26 and is targeting a similar sales increase of around 3% by 2028. For the fiscal year the company gave an EBITDA margin of 19–20%; adjusted EBITDA recently fell by 2.1% to €343.1m, and the adjusted operating margin dropped to 19.3%. Net income was €158.4m, and the dividend is to be raised by €0.05 to €1.30 per share. The figures and the outlook missed analysts’ expectations, after which the stock fell sharply. » More on finanzen.net

KWS reported a 3% decline in sales for fiscal year 2025/26 to €1,626.8m and an EBITDA of €343.1m (margin 21.1%), with a one‑off effect from license sales boosting the figures. Adjusted EBITDA would be €314.1m with a margin of 19.3%. Net income rose by about 13% to €158.4m thanks to an improved financial result. For 2026/27 management plans 3% sales growth and an EBITDA margin of 19–21%, which disappointed investors and led to sharp share price losses; the 200‑day line around €72 could provide short‑term support. » More on finanzen.net